Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016)
Amarin Corp Plc\Uk (AMRN) posted quarterly Current Deferred Tax Assets of $900000.0 for Q4 2016, up 200.0% year-over-year from $300000.0 in Q1 2016, and up 200.0% quarter-over-quarter from -$900000.0 in Q4 2015.
Amarin Corp Plcuk (AMRN) Current Deferred Tax Assets (2010 - 2016) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Current Deferred Tax Assets for 7 consecutive years, with $900000.0 the latest figure, recorded in Q4 2016.
- In Q4 2016, Current Deferred Tax Assets rose 200.0% year-over-year to $900000.0; the TTM figure through Dec 2016 stood at $900000.0 (up 200.0% YoY), while the FY2016 annual figure was $900000.0, up 200.0% from the prior year.
- Current Deferred Tax Assets climbed to $900000.0 in Q4 2016 per AMRN's latest filing, from -$900000.0 in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $937000.0 in Q4 2012 and bottomed at -$900000.0 in Q4 2015.
- Historically, Current Deferred Tax Assets has averaged $645000.0 across 5 years, with a median of $900000.0 in 2016.
- Annual changes were most pronounced in 2015 — Current Deferred Tax Assets slumped 196.36% — and 2016, when it jumped 200.0%.
- Amarin Corp Plc\Uk's Current Deferred Tax Assets stood at $937000.0 in 2012, then slumped by 49.73% to $471000.0 in 2013, then soared by 98.3% to $934000.0 in 2014, then plunged by 196.36% to -$900000.0 in 2015, then surged by 200.0% to $900000.0 in 2016.
- Business Quant data shows AMRN's Current Deferred Tax Assets at $900000.0 in Q4 2016, -$900000.0 in Q4 2015, and $934000.0 in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 900,000.00 |
| Dec 31, 2016 | 900,000.00 |
| Dec 31, 2015 | -900,000.00 |
| Dec 31, 2015 | -900,000.00 |
| Sep 30, 2015 | 934,000.00 |
| Sep 30, 2015 | 934,000.00 |
| Jun 30, 2015 | 934,000.00 |
| Jun 30, 2015 | 934,000.00 |
| Mar 31, 2015 | 934,000.00 |
| Mar 31, 2015 | 934,000.00 |
| Dec 31, 2014 | 934,000.00 |
| Dec 31, 2014 | 934,000.00 |
| Sep 30, 2014 | 471,000.00 |
| Sep 30, 2014 | 471,000.00 |
| Jun 30, 2014 | 471,000.00 |
| Jun 30, 2014 | 471,000.00 |
| Mar 31, 2014 | 471,000.00 |
| Mar 31, 2014 | 471,000.00 |
| Dec 31, 2013 | 471,000.00 |
| Dec 31, 2013 | 471,000.00 |